Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia
Yuichiro Nakata(University of Miami), Hiroaki Honda(Tokyo Women's Medical University), Norimasa Yamasaki(Hiroshima University), Toshiya Inaba(Hiroshima University), Masashi Sanada(Nagoya Medical Center), Seishi Ogawa(Keio University), Keiyo Takubo(Keio University), Toshio Suda(Chinese Academy of Sciences), Kenichiro Ikeda(Hiroshima University), Yasuhiro Ebihara(Saitama Medical University), Akinori Kanai(Frontier Medical College), Linda Wolff(National Institutes of Health), Takeshi Ueda(Kindai University), Yasuyuki Sera(Tokyo Women's Medical University), Zen‐ichiro Honda(Ochanomizu University), Kohichiro Tsuji(Tokyo Medical University), Hideaki Oda(Hakodate Central General Hospital), Akiko Nagamachi(Hiroshima University)
Cited by 29
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771